TIVDAK (tisotumab vedotin-tftv) is a treatment for patients with recurrent/metastatic cervical cancer that received full FDA approval in April 2024 and launched with our co-promote partner, Genmab. This is an exciting opportunity to work on a fast-paced, co-promote with a high performing team and to support patients with advanced cervical cancer. The HCP Marketing Director is responsible for creating and developing a full promotional strategy and related tactics for TIVDAK. This role will work closely with cross-functional partners to identify tactics that advance our business objectives. This role is responsible for optimizing marketing mix, asset development, and strategic deployment across channels. As TIVDAK is co-commercialized with Genmab in the United States, the US HCP Marketing Director is responsible for leading all promotional activities and ensuring alignment across cross-functional teams including co-promote partner. Pfizer owns all marketing responsibilities within the US for TIVDAK.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
5,001-10,000 employees